PSYCONN
Psychosis Cohort Northern Netherlands...
Description
PSYCONN (=Psychosis Cohort Northern Netherlands) is a combination of 3 datasets from the northern part of the Netherlands; PROGR-S (=Psychosis Recent Onset GRoningen Survey), PHAMOUS (=Pharmacotherapy Outcome and Monitoring Survey) and RQ-MIS (=RoQua...
General Design
- Type
- Cohort study
- Cohort type
- Clinical cohort
- Design
- Longitudinal
- Start/End data collection
- 1998 until 2018
- License
- https://license-placeholder.nl
Population
- Countries
- Netherlands (the)
- Regions
- Drenthe, Friesland, Groningen
- Number of participants
- 1000
- Population age groups
- Adult (18+ years)
- Main medical condition
- V Mental and behavioural disorders
- F20-F29 Schizophrenia, schizotypal and delusional disorders
- F20 Schizophrenia
- F20.0 Paranoid schizophrenia
- F20.1 Hebephrenic schizophrenia
- F20.2 Catatonic schizophrenia
- F20.3 Undifferentiated schizophrenia
- F20.4 Schizophrenia - Post-schizophrenic depression
- F20.5 Residual schizophrenia
- F20.6 Simple schizophrenia
- F20.8 Other schizophrenia
- F20.9 Schizophrenia, unspecified
- F21 Schizotypal disorder
- F22 Persistent delusional disorders
- F22.0 Delusional disorder
- F22.8 Other persistent delusional disorders
- F22.9 Persistent delusional disorder, unspecified
- F23 Acute and transient psychotic disorders
- F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
- F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
- F23.2 Acute schizophrenia-like psychotic disorder
- F23.3 Other acute predominantly delusional psychotic disorders
- F23.8 Other acute and transient psychotic disorders
- F23.9 Acute and transient psychotic disorder, unspecified
- F24 Induced delusional disorder
- F25 Schizoaffective disorders
- F25.0 Schizoaffective disorder, manic type
- F25.1 Schizoaffective disorder, depressive type
- F25.2 Schizoaffective disorder, mixed type
- F25.8 Other schizoaffective disorders
- F25.9 Schizoaffective disorder, unspecified
- F28 Other nonorganic psychotic disorders
- F29 Unspecified nonorganic psychosis
- F30-F39 Mood [affective] disorders
- F30.2 Manic episode - Mania with psychotic symptoms
- F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms
- F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms
- F32.3 Severe depressive episode with psychotic symptoms
- F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms
Organisations
Lead organisations
- GGZ Drenthe
- GGZ Friesland
- Lentis Research
- University Medical Center Groningen (UMCG)Netherlands (the)
Contributors
Subpopulations
List of subpopulations for this resource...
| Name | Description | Number of participants | |
|---|---|---|---|
No results for current selection |
Collection events
List of collection events defined for this resource...
| Name | Description | Participants | Start end year | |
|---|---|---|---|---|
No results for current selection |
Networks
Part of networks...
Access conditions
IPEC set up a virtual databank and implemented a technical infrastructure for remote federated analysis of individual-level data of psychosis patients. With this platform, individual patient data remains stored on local servers of participating insti...
- Release type
- Periodically
Funding & Acknowledgements
- Funding
- IPEC was supported by the 2020 SIRS Research Harmonization Group Award which included a grant in the amount of $5000 USD to Prof. Wim Veling and Prof. Craig Morgan; an internal MD-PhD research grant of the University Medical Center Groningen (grant number 18-41) to Vera Brink, MSc; a grant in the amount of 400,000 DKK of the Capital Regions Research council to Dr Nikolai Albert; and the participating institutions (Lentis Psychiatric Institute, GGZ Drenthe, GGZ Friesland, University Center Psychiatry of University Medical Center Groningen, Bispebjerg hospital, Psychiatric Hospital Risskov, and Psychiatric Centre Copenhagen).
- Acknowledgements
- IPEC wishes to acknowledge the services of all the study participants, staff, research groups, and institutions collaborating in IPEC, and of MOLGENIS and RoQua, who helped build and maintain the technical infrastructure.